There are currently 441 active clinical trials seeking participants for Breast Cancer research studies. The states with the highest number of trials for Breast Cancer participants are California, Ohio, Illinois and Michigan.
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT06305312
Recruiting
The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast cancer screening results. The investigators will determine the effectiveness of social needs referrals combined with a community services navigation intervention in the screening mammography setting to improving breast screening outcomes in underserved women.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/22/2024
Locations: University of Utah Health Hospitals/Huntsman Cancer Institute Population Sciences, Salt Lake City, Utah
Conditions: Breast Cancer
Register for Updates
Breast Elasticity Imaging During Neoadjuvant Chemotherapy
NCT04824027
Recruiting
For this study, the investigators propose investigation of a new imaging technique, Harmonic Motion Imaging (HMI), and the evaluation of its potential role in prediction of breast cancer response to neoadjuvant chemotherapy (NACT). The investigators hypothesize that changes in HMI parameters will predict response to neoadjuvant systemic therapy in early-stage breast cancer.
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
05/22/2024
Locations: Columbia University Irving Medical Center/NYP, New York, New York
Conditions: Breast Cancer
Register for Updates
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
NCT04614194
Recruiting
The purpose of this study is to better understand how the immune system plays a role in fighting breast cancer and specifically research if the immune system response against breast cancer can be improved with endocrine therapy and cyclin dependent kinase inhibitor therapy in patients with hormone receptor positive breast cancer. This will be studied by collecting tumor tissue and blood samples before and after 2 weeks of study treatment with commonly used endocrine therapy and cyclin dependent... Read More
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
05/17/2024
Locations: Parkland Hospital, Dallas, Texas +1 locations
Conditions: Breast Cancer
Register for Updates
SABER Study for Selected Early Stage Breast Cancer
NCT04360330
Recruiting
The purpose of this study is to find the most effective dose of radiation therapy to give to breast tumors in a shorter period of time, prior to standard partial mastectomy/axillary surgery.
Gender:
FEMALE
Ages:
50 years and above
Trial Updated:
05/15/2024
Locations: University of Miami, Miami, Florida
Conditions: Breast Cancer, Early-stage Breast Cancer
Register for Updates
A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care
NCT06397651
Recruiting
A Decentralized, Double-blinded, Randomized, 18 month, Parallel-group, Superiority Study to evaluate the impact of Complement Theory's Live 1:1 Exercise Coaching and Personalized Digital Application on Cancer Survivors' Cost of Care
Gender:
ALL
Ages:
Between 21 years and 64 years
Trial Updated:
05/15/2024
Locations: Complement Theory Inc., Dover, Delaware
Conditions: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Other Cancer
Register for Updates
Magnetic Resonance Imaging of Breast Cancer
NCT01035112
Recruiting
To compare magnetic resonance imaging (MRI) with more well established diagnostic imaging techniques to determine which method best finds and defines breast cancer.
Gender:
FEMALE
Ages:
21 years and above
Trial Updated:
05/15/2024
Locations: Stanford University School of Medicine, Stanford, California
Conditions: Breast Cancer, Breast Cancer Non-invasive Breast Cancer
Register for Updates
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer
NCT04766190
Recruiting
The DISCO App is designed to improve, during the interaction, patient active participation and patient-initiated oncologist treatment cost discussions, and, in the short term, patient's treatment cost knowledge, self-efficacy for managing both cost and physician interactions, referrals, perceived financial toxicity (i.e., distress and material hardship); in turn, these will affect longer-term outcomes of financial toxicity and adherence.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/14/2024
Locations: Barbara Ann Karmanos Cancer Institute, Detroit, Michigan
Conditions: Financial Toxicity, Cancer, Question Prompt List, Breast Cancer, Prostate Cancer
Register for Updates
Biomarkers to Detect Endocrine Therapy Resistance
NCT06067503
Recruiting
This pilot observational study is being done to identify possible biomarkers of response to endocrine therapy in patients with ER/PR+ metastatic lobular breast cancer (LBC) starting new endocrine therapy. 18F-fluorofuranylnorprogesterone Positron Emission Tomography/Computed Tomography (FFNP-PET/CT) and liquid biopsies will be performed at baseline and after 4 weeks of treatment. Baseline levels and dynamic on-treatment changes in estrogen signaling as measured by FFNP-PET/CT and circulating tum... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/13/2024
Locations: UW Carbone Cancer Center, Madison, Wisconsin
Conditions: Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma
Register for Updates
Testing Conversation Aid in Practice
NCT06011434
Recruiting
The goal of this research study is to develop and test a website to help primary care providers (PCPs) discuss the pros and cons of mammography with women aged 75 and older and to help participants make decisions about mammography.
Gender:
FEMALE
Ages:
Between 75 years and 89 years
Trial Updated:
05/07/2024
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Breast Cancer
Register for Updates
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
NCT02926729
Recruiting
This research is studying a new investigative imaging instrument called a nonlinear microscope (NLM). A nonlinear microscope can produce images similar to an ordinary pathologist's microscope, but without first processing tissue to make slides. This study will determine if a NLM can be used to evaluate tissue during lumpectomy surgery for breast cancer in order to reduce the probability that standard pathologic examination of the specimen after the end of the operation will find close or positiv... Read More
Gender:
FEMALE
Ages:
21 years and above
Trial Updated:
05/07/2024
Locations: Beth Israel Deaconess Medical Center, Boston, Massachusetts
Conditions: Breast Cancer
Register for Updates
Adherence Intervention in Patients With Metastatic Breast Cancer
NCT06121453
Recruiting
To evaluate the preliminary efficacy of a multicomponent adherence intervention focused on enhancing digital equity and pharmaco-equity among nonadherent patients with metastatic breast cancer (MBC) and cardiovascular disease (CVD) risk factors on endocrine therapy (ET), CDK4/6 inhibitor (CDK 4/6i), and CVD medications. To assess the acceptability and appropriateness of this intervention in patients with MBC and CVD risk factors through validated measures of implementation outcomes. To gain a de... Read More
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
05/07/2024
Locations: Columbia University Medical Center, New York, New York
Conditions: Breast Cancer
Register for Updates
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
NCT04877912
Recruiting
The purpose of this study is to test an innovative MRI breast cancer screening method in women with mammographically dense breasts as well as other women with moderately increased cancer risk. MRI, combined with other methods of risk assessment, has potential to significantly improve sensitivity to cancer in dense breasts and detect cancer in all cases at a much earlier stage, with far fewer interval cancers than mammography. Previous tests of MRI sensitivity show that this screening could signi... Read More
Gender:
FEMALE
Ages:
Between 40 years and 74 years
Trial Updated:
05/03/2024
Locations: University of Chicago Mitchell Hospital, Chicago, Illinois
Conditions: Breast Cancer
Register for Updates